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Background Zea mays L. (Poacae), also called maize or corn, is used for its nutritive value. Parts of the plant such as 
maize grains, leaves, cornsilks, stalk, and inflorescence are also employed in ethnomedicine Warm tea made from the 
husk and leaf is taken in traditional medicine for the treatment of malaria, depression and other diseases. 
Objective: Evaluation of antidepressant activity of the leaf extract was carried out to ascertain its ethnomedicinal 
uses. 
Method:  The ethanol leaf extract of Zea mays (170 - 510 mg/kg) was investigated for antidepressive activity in open 
field, force swimming, and tail suspension tests using Swiss albino mice.  
Results: The extract was found to significantly (p<0.05-0.01) increase the frequency of line crossing, rearing and 
walling activities of mice in open field test. The extract also decreased significantly (p<0.05-0.001) duration of 
immobility time of mice in force swimming and tail suspension tests.  
Conclusion: The results of this study suggest that leaf extract of Z. mays has antidepressant activity and this lay 
credence to its use in ethno-medicine for the treatment of depression.  
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1. Introduction 
Zea mays L. (Family- Poacae) also called maize or corn, 
is an annual grass plant whose seeds are used for its 
nutritive value as well as animal feed.  It was introduced 
to Nigeria some centuries ago from South America 
(Osagie and Eka, 1998). It is tall with fibrous root 
system and long narrow leaves. The ears are enclosed in 
modified leaves known as husks (Simmonds, 1979).  In 
addition to other uses of the plant, maize grains, leaves, 
cornsilks, stalk, and inflorescence are employed in 
ethnomedicine for the treatment of several ailments. 
For example, corn silk is used as an antidiabetic or 
diuretic, and decoction of the silk is taken for the 
treatment of urinary troubles and gallstones (Foster 
and Duke, 1990; Gill, 1992; Abo et al, 2008). The ash of 
the cob is used for the treatment of cough (Gill, 1992) as 
well as inflammatory diseases. The husks are used in 
the treatment of pains and arthritis (Owoyele et al, 
2010). Warm tea made from the husk and leaf is taken 
for the treatment of malaria, depression and other 
diseases in Ibibio traditional medicine. Biological 
activities reported on the leaf extract include; 
anticancer (Balasubramanian et al, 2014), antioxidant 
(Balasubramanian and Padma, 2012) and antioxidative 
stress (Balasubramanian and Padma, 2013a; 
Balasubramanian and Padma, 2013b; Balasubramanian 
et al, 2015), anti-inflammatory and analgesic (Okokon 
et al, 2016), antimalarial and antiplasmodial (Okokon et 
al, 2017) activities. Information on the biological 
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activities of the leaf extract is scarce. We report in this 
study the antidepressant activity of the leaf extract in 
mice. 
2. Methods 
2.1 Plant material 
The fresh leaves of Zea mays were collected in August, 
2015 at farmland in Uyo village in Uyo LGA, Akwa Ibom 
State, Nigeria. The leaves were identified and 
authenticated as Zea mays at the Department of Botany 
and Ecological studies, University of Uyo, Uyo, Nigeria. A 
herbarium specimen (FPH, 614) was deposited at the 
Faculty of Pharmacy Herbarium, University of Uyo, Uyo. 
2.2 Extraction 
The plant parts (leaves) were washed and air- dried on 
laboratory table for 2 weeks. The dried leaves were 
pulverized using a pestle and mortar. The powdered 
leaf was macerated in 95% ethanol for 72 hours. The 
liquid ethanol extract obtained by filtration was 
evaporated to dryness in a rotary evaporator 40˚C. The 
extract was stored in a refrigerator at 4˚C until used for 
experiment reported in this study. 
2.3 Experimental Animals 
The animals (Swiss albino mice) of either sex were used 
for these experiments. The animals were housed in 
standard cages and were maintained on a standard 
pelleted feed (Guinea feed) and water ad libitum. 
Permission and approval for animal studies were 
obtained from the College of Health Sciences Animal 
Ethics Committee, University of Uyo. 
2.4 Evaluation of antidepressant activity 
2.4.1 Open field test  
Mice were randomly divided into groups of 5 mice each 
and treated as follows for 5 days before open field test;  
control (normal saline, 2 ml/kg p.o.), imipramine (5.0 
mg/kg, p.o.) and ethanol leaf extract of Zea mays (170, 
340, and 510 mg/kg, p.o.). The open-field arena was 
made of acrylic (transparent walls and black floor, 30 × 
30 × 15 cm), divided into nine squares of equal areas. 
The open field was used to evaluate the exploratory 
activity of the animal (Archer, 1973). The observed 
parameters were the number of squares crossed (with 
the four paws) and number of walling and rearing 
activities, recorded for 5 min testing period. 
2.4.2 Forced swimming test  
Mice were randomly divided into groups of 5 mice each 
and treated as follows for 5 days before the behavioural 
test;  control (normal saline, 2 ml/kg p.o.), imipramine 
(5.0 mg/kg, p.o.) and ethanol leaf extract of Zea mays 
(170, 340, and 510 mg/kg, p.o.). For assessing 
antidepressant activities, we employed the method 
described by Porsolt et al. (1977; 1978). The 
development of immobility when mice were placed 
inside an inescapable cylinder filled with water reflects 
the cessation of persistent escape-directed behavior. 
Briefly, mice were individually placed in a circular tank 
(46 cm tall × 20 cm in diameter) filled with tap water 
(25 ± 1°C) to a depth of 20 cm and left there for 5 min. 
During this period, the behavior of the animals was 
recorded by an observer. Mice were considered 
immobile when remained floating without struggling 
and making only slight movements necessary to 
maintain the head above the water. 
2.4.3 Tail suspension test (TST)  
Mice  of either sex were randomly divided into groups 
of 5 mice each and treated as follows for 5 days before 
tail suspension test;  control (normal saline, 2 ml/kg 
p.o.), imipramine (5.0 mg/kg, p.o.) and ethanol leaf 
extract of Zea mays (170, 340, and 510 mg/kg, p.o.). The 
total duration of immobility induced by tail suspension 
was measured according to the methods described by 
Steru et al, (1985). Briefly, mice both acoustically and 
visually isolated were suspended 50 cm above the floor 
by adhesive tape placed approximately 1 cm from the 
tip of the tail. Immobility time was recorded during a 6 
min period. Mice were considered immobile only when 
they hung passively and were motionless. 
2.5 Statistical analysis  
Data obtained from this work were analyzed 
statistically using  ANOVA (One-way) followed by a post 
test (Tukey-Kramer multiple comparison  test). 
Differences between means were considered significant 
at 5% level of significance (p ≤ 0.05).  
3. Results  
Open field test 
Administration of leaf extract of Zea mays (170 – 510 
mg/kg) for 5 days caused significant (p<0.05 – 0.01) 
dose-dependent increase in the frequency of line 
crossing when compared to control. The standard 
drugs, imipramine (5 mg/kg), caused a significant 
(p<0.001) higher increase in the locomotor activity of 
the mice than the extract (170-150 mg/kg) as evident in 
the frequency of the line crossing (Table 1). 
Zea mays leaf extract (170 – 510 mg/kg) caused 
prominent increase in walling frequency of the mice 
which was significant (p<0.05) when compared to 
control. These effects were dose-dependent. The effects 
of the extract in all doses administered were lower 
compared to that of the standard drug, imipramine. The 
standard drug, imipramine (5 mg/kg), produced a 
significant (p<0.001) increase in the walling frequency 
of the animals (Table 1). 
The leaf extract of the Zea mays (170 – 510 mg/kg) 
caused significant (p<0.001) dose – dependent increase 
of the rearing frequency of mice administered with the 
extract for five days.  However, these effects were lower 
compared to that of the standard drug, imipramine. 
Similarly, the standard drug, imipramine (5 mg/kg), 
exerted a significant (p<0.001) increase in the rearing 
frequency when compared to control (Table 1). 
Effect on force swimming test 
Administration of the ethanol leaf extract of Zea mays 
(170 – 510 mg/kg) to mice for five days significantly 
(p<0.05-0.01) reduced immobility duration dose-
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dependently in mice during force swimming test when 
it was compared to control.  The standard drug, 
imipramine (5 mg/kg) similarly produced a significant 
(p<0.001) reduction in the immobility time of the mice 
when compared to control (Table 2). The effect of the 
highest dose of the extract (510 mg/kg) was 
comparable to that of the standard drug, imipramine. 
 




Line Crossing Walling Rearing 
Control normal saline - 29.23 ±2.78 6.28 ± 1.30 2.21± 0.14 
Imipramine 5 84.24 ±3.18b 24.30 ± 2.17a 7.20±0.15b 
Crude extract 170 68.95±2.76b 14.12 ± 1.34 6.25±0.25b 
340 76.34 ± 2.75b 22.45 ± 2.54a 7.24±1.45b 
510 81.38 ± 4.39b 30.14 ±5.12 10.62±0.16 
Data are expressed as MEAN ± SEM, Significant at ap < 0.05, bp<0.001, when compared to control. (n=6). 
 




Duration Of Immobility 
(Sec) 
Control normal saline - 120.24±6.92 
Imipramine 5 88.56±5.60 c 
Extract 170 101.22± 6.55a 
340 95.14± 4.28 b 
510 90.27± 6.29 b 
Data are expressed as MEAN ± SEM, Significant at ap < 0.05, bp<0.01, cp<0.001, when compared to control. (n=6). 
 




Duration Of Immobility(Sec) 
Control normal saline - 120.10±6.39 
Imipramine 5 76.37±5.38b 
Crude extract 170 92.36±5.84 a 
340 87.15±4.38b 
510 71.19±6.45 b 
Data are expressed as MEAN ± SEM, Significant at ap <0.01; bp< 0.001, when compared to control. (n=6). 
 
Effect on tail suspension test 
Administration of the ethanol leaf extract of Zea mays 
(170 – 510 mg/kg) to mice for five days significantly 
(p<0.001) reduced immobility duration dose-
dependently during tail suspension test when it was 
compared to control.  
The standard drug, imipramine (5 mg/kg), exerted a 
significant (p<0.001) reduction of the immobility time 
of the mice when compared to control (Table 3). The 
effect of the highest dose of the extract (510 mg/kg) 
was comparable to that of the standard drug, 
imipramine. 
4.0 Discussion 
In this study, evaluation of the effect of ethanol leaf 
extract of Zea mays on central nervous system was 
carried out in mice using different models; Open field 
test, tail suspension test and force swimming test. The 
leaf extract (170 – 510 mg/kg) was found to cause 
significant non-dose-dependent increases in the 
frequency of line crossing, walling and rearing activities 
of the pretreated mice. It also reduced significantly the 
immobility time of the mice in force swimming and tail 
suspension tests.  
Monitoring of locomotor activity of animals has been 
used in assessing effect of drug on the CNS. An 
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increased movement is a measure of the level of 
excitability of the CNS (Ozturk et al, 1996) and its 
decrease may be intimately related to sedation resulting 
from depression of the CNS (Kolawole et al, 2007). 
Central nervous system stimulants are known to 
increase locomotor activity, while agents with 
depressant activity cause reduction in movements 
(Yadav et al, 2008). The leaf extract was found to 
increase significantly line crossing, walling and rearing 
activities during open field test suggesting stimulatory 
effect on the CNS. 
The CNS stimulatory effect of the leaf extract was 
further supported by its potential to reduce immobility 
time of mice during force swimming and tail suspension 
tests.  Forced swimming and tail suspension tests are 
two of the most commonly used animal models of 
depression for antidepressant screening. In the forced 
swimming test, the development of immobility when 
mice are placed into an inescapable cylinder of water 
reflects the cessation of persistent escape-directed 
behavior (Lucki, 1997). The tail suspension test is based 
on the fact that animals subjected to the short-term, 
inescapable stress of being suspended by their tail, will 
develop an immobile posture. Various antidepressants 
are able to reverse the immobility and promote the 
occurrence of escape related behavior. Both models of 
depression are widely used to screen new 
antidepressants (Porsolt et al, 1977, 1978; Steru et al, 
1985). These tests are quite sensitive to major 
antidepressant drugs including tricyclics, serotonin-
specific reuptake inhibitors, MAO inhibitors, and 
atypical antidepressant (Porsolt et al, 1977; Steru et al, 
1985). 
Forced swimming and tail suspension tests which 
represent the behavioural despair model, claimed to 
reproduce a condition similar to human depression 
(Porsolt et al, 1977; Willner, 1984; Steru et al, 1985). 
The tests are based on the observation that animals, 
following initial escape oriented movements, develop 
an immobile posture when placed in an inescapable 
chamber. The immobility is thought to reflect either a 
failure of persistence in escape-directed behaviour (i.e. 
behavioural despair) or the development of passive 
behaviour that disengages the animal from active forms 
of coping with stressful stimuli (Lucki, 1997). It is well 
known that clinically effective antidepressants (such as 
imipramine) typically increase the swimming efforts of 
the animal seeking a solution to the problem and, 
therefore, they decrease the duration of immobility in 
the forced swimming test (Porsolt et al, 1977). This was 
observed in this study. 
Similarly, the results of this study suggest that the leaf 
extract exhibited significant antidepressant activity 
with a strong psychomotor stimulation. These findings 
corroborates that reported on corn husk extract by 
Okokon et al, (2016). Phytochemical constituents such 
as flavonoids have been implicated in antidepressant 
action on the CNS (Hossain et al, 2009), while 
polyphenols especially flavonoids like quercetin and 
rutin have also been reported to exhibit antidepressant 
effect (Nolder and Schotz, 2002). The leaf extract of Z. 
mays have been reported to contain some phenolics 
such as p-Hydroxycinnamic acid and polyunsaturated 
fatty acids such as 9-Octadecenoic acid (Z)-, 2- 
hydroxyethyl ester, ethyl 9,12,15-
octadecatrienoate,9,12,15-Octadecatrien-1-ol, ethyl 
(9Z,12Z)-9,12-octadecadienoate and  hexadecanoic acid, 
ethyl (Okokon et al, 2017).  These polyunsaturated fatty 
acids are known to possess antidepressant activity 
(Naveen et al, 2013; Su et al, 2015). Omega-3 PUFAs 
have been suggested to provide a range of 
neurobiological activities through modulation of 
neurotransmitters, anti-inflammation, anti-oxidation 
and neuroplasticity thereby exerting antidepressant 
action (Su, 2008; Lu et al, 2010; Su, 2012; Su et al, 2015) 
These phytochemical constituents may be responsible 
for the observed activity of the leaf extract in this study. 
5.0 Conclusion  
The results of this study suggest that the leaf extract of 
Zea mays possess antidepressant activity which maybe 
due to the phytochemical compounds present in the 
leaf. 
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